Skip to content

Insider · CIK 0001184627

Dennis M Fenton

director

Files at ANAB (ANAPTYSBIO, INC). First filing Jun 20, 2025, latest Jun 20, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $72k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ANAB: ANAPTYSBIO, INC

ANABOct 9, 2026 · close 45.95

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
21Weak
ANABsell 210b5-1
ANAPTYSBIO, INC
$72k
3,015 shares
-38%+89% from low-42% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 18, 2025ANAB
ANAPTYSBIO, INC
SOpen-market sale
Common Stock10b5-1
-3,015$23.97$72k4,965Jun 20, 2025
Jun 15, 2025ANAB
ANAPTYSBIO, INC
MOption exercise
Common Stock
+6,030$0.00$07,980Jun 17, 2025
Jun 15, 2025ANAB
ANAPTYSBIO, INC
MOption exercise
Restricted Stock Unitderivative
-6,030$0.00$00Jun 17, 2025
Jan 7, 2025ANAB
ANAPTYSBIO, INC
AGrant or award
Stock Option (right to buy)derivative
+16,510$0.00$016,510Jan 7, 2025
Jan 7, 2025ANAB
ANAPTYSBIO, INC
AGrant or award
Restricted Stock Unitderivative
+6,030$0.00$06,030Jan 7, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dennis M Fenton: insider trades and track record | InsiderTell